2021

1. Dual and opposite costimulatory targeting with a novel human fusion recombinant protein effectively prevents renal warm ischemia reperfusion injury and allograft rejection in murine models

   International Journal of Molecular Sciences, Vol. 22, Núm. 3, pp. 1-19